JINGXIN(SZ:002020) Xin Lang Cai Jing·2025-10-13 03:41Core Viewpoint - Jingxin Pharmaceutical's stock price has experienced fluctuations, with a year-to-date increase of 54.30% but a recent decline in the last five and twenty trading days [1][2]. Financial Performance - For the first half of 2025, Jingxin Pharmaceutical reported revenue of 2.017 billion yuan, a year-on-year decrease of 6.20%, and a net profit attributable to shareholders of 388 million yuan, down 3.54% year-on-year [2]. - The company has cumulatively distributed 2.11 billion yuan in dividends since its A-share listing, with 801 million yuan distributed over the past three years [3]. Stock Market Activity - As of October 13, the stock price was 19.24 yuan per share, with a market capitalization of 16.566 billion yuan. The trading volume was 156 million yuan, with a turnover rate of 1.11% [1]. - The stock has appeared on the "Dragon and Tiger List" once this year, with a net buy of 111 million yuan on July 4 [1]. Shareholder Information - As of June 30, 2025, the number of shareholders was 25,700, a decrease of 0.11% from the previous period, with an average of 28,196 circulating shares per shareholder, an increase of 0.11% [2]. - Hong Kong Central Clearing Limited is the fifth-largest circulating shareholder, holding 9.6492 million shares, a decrease of 15.3917 million shares from the previous period [3].